Skip to content

Drug interactions

Fedratinib + Ticlopidine

Severity: Moderate

Fedratinib and Ticlopidine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fedratinib inhibits CYP3A4, CYP2C19 and CYP2D6 and could raise ticlopidine levels, increasing the risk of adverse effects such as neutropenia. Ticlopidine also inhibits CYP2C19 and CYP2D6, which may raise fedratinib exposure to a small degree.

What this interaction means in plain words

Fedratinib and Ticlopidine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Fedratinib belongs to Oncology; Ticlopidine belongs to Cardiovascular.

Evidence level: Low

Why it happens

Fedratinib inhibition of CYP3A4 and CYP2C19 reduces ticlopidine clearance; ticlopidine may modestly inhibit fedratinib metabolism.

What to do

Monitor complete blood counts closely and watch for bleeding or infection; adjust therapy if cytopenias develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fedratinib and Ticlopidine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Fedratinib with Ticlopidine?

MediHelp rates the interaction as moderate. Fedratinib and Ticlopidine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Fedratinib inhibits CYP3A4, CYP2C19 and CYP2D6 and could raise ticlopidine levels, increasing the risk of adverse effects such as neutropenia. Ticlopidine also inhibits CYP2C19 and CYP2D6, which may raise fedratinib exposure to a small degree.

How serious is the interaction between Fedratinib and Ticlopidine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts closely and watch for bleeding or infection; adjust therapy if cytopenias develop.

What other medicines interact with Ticlopidine?

MediHelp also lists interactions of Ticlopidine with, for example, Mavacamten, Abrocitinib, Acetylsalicylic acid. The full list is on the Ticlopidine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in